Publikationen, an denen er mitarbeitet Luis Rodríguez Rodríguez (14)

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  2. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Scientific Reports, Vol. 7

2016

  1. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: A genetic study of six cohorts

    Arthritis Research and Therapy, Vol. 17, Núm. 1

2013

  1. Evidence of association of the NLRP1 gene with giant cell arteritis

    Annals of the Rheumatic Diseases

2012

  1. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

2011

  1. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601

  2. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases

  3. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis

    Clinical and Experimental Rheumatology

  4. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 5, pp. 889-892

  5. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis

    Human Immunology, Vol. 72, Núm. 5, pp. 458-461